Industry / South Korea
Introduction Of Cervical Cancer Vaccine Delayed
May 2008 | Company News AlertThe South Korean authorities have pushed back a decision to include MSD Korea's cervical cancer vaccine, Gardasil, in the national immunisation programme. BMI believes the development is a blow to the manufacturer as it allows GlaxoSmithKline Korea's rival preventative, Cervarix, an opportunity to compete for the lucrative
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
